Keyphrases
Kidney Transplant Recipients
100%
United States
78%
Induction Type
73%
Graft Outcome
56%
Recipient Survival
55%
Kidney Transplant Outcomes
52%
Mycophenolic Acid
52%
Area under the Curve
52%
Enterohepatic Recirculation
52%
Living Donor
49%
Interleukin-2 Receptor Antagonist
43%
Restricted Sampling
41%
Graft Survival
38%
Death-censored Graft Survival
37%
Antithymocyte Globulin
32%
Alemtuzumab
30%
Lupus Nephritis
30%
Nephritis
30%
High Risk
30%
Tacrolimus
29%
Transplantation
28%
Glomerulonephritis
26%
Dialysis-dependent
26%
Relationship Outcomes
26%
Living Donor Kidney Transplantation
26%
Donor-recipient Matching
26%
Donor Kidney
26%
Genotype
26%
AIDS/HIV
26%
Kidney Allograft
26%
Kidney Allograft Biopsy
26%
Deceased Donor
26%
Kidney Graft
26%
Nucleic Acid Testing
26%
Podocyte
26%
Fibronectin Glomerulopathy
26%
Apolipoprotein L1 (APOL1)
26%
Lower Motor Neuron
26%
Facial Palsy
26%
Etiology
26%
Systemic Lupus Erythematosus
26%
Cranial Nerve Palsy
26%
Inverse Probability of Treatment Weighting
26%
Weight Analysis
26%
Induction Immunosuppression
26%
Egfr
26%
Body Surface
26%
Simultaneous Prediction
26%
Mycophenolate Mofetil
23%
Scientific Registry of Transplant Recipients
23%
Medicine and Dentistry
Kidney Graft
85%
Graft Survival
64%
Allograft
52%
Kidney Allograft
52%
Living Donors
52%
Nephritic Syndrome
34%
Podocyte
26%
Apolipoprotein L1
26%
Glomerulonephritis
26%
Human Immunodeficiency Virus
26%
Nucleic Acid
26%
Lupus Nephritis
26%
Glomerulopathy
26%
Systemic Lupus Erythematosus
26%
Cranial Nerve Paralysis
26%
Facial Nerve Paralysis
26%
Fibronectin
26%
Biopsy Technique
26%
Body Surface
26%
Proportional Hazards Model
18%
Focal Segmental Glomerulosclerosis
17%
Biological Product
17%
Immunoglobulin A
17%
Acute Graft Rejection
13%
Proteinuria
13%
Kaplan Meier Method
13%
Membranoproliferative Glomerulonephritis
10%
Creatinine
10%
Iohexol
10%
Plasma Clearance
10%
Mycophenolic Acid
8%
Sm Antibody
8%
Lupus Erythematosus
8%
Common Cold Symptom
8%
Membranous Glomerulonephritis
8%
Renal Biopsy
8%
Tacrolimus
8%
Facial Droop
8%
Pulse Rate
8%
Antinuclear Antibody
8%
Mycophenolate Mofetil
8%
HIV Test
7%
Hazard Ratio
7%
Nephropathy
5%
Immunofluorescence Microscopy
5%
Case Presentation
5%
Genetic Counseling
5%
Delayed Graft Function
5%
End Stage Renal Disease
5%
Human Immunodeficiency Virus Antibody
5%